Reached our customers within 24-48 hours of them placing them (Mondays Fridays)
This distinguishes tirzepatide from SGLT2 inhibitors, which do carry an elevated UTI risk because they increase glucose in urine, providing a growth medium for bacteria
Deloitte Warns of a GLP-1 "Bubble" A new report from Deloitte suggests soaring demand for obesity and diabetes drugs may be creating a "bubble effect" within the pharmaceutical industry, as quoted on CNBC.
For employers that aren't covering GLP-1s for weight loss, however, or are considering limiting coverage, the alternative isn't simply avoidance
Personalized support can make a significant difference in sustaining your weight loss efforts
We can also access it from fortified foods, such as cereals, but foods rich in vitamin B12 may not always do their job properly